Cite
HARVARD Citation
LeBlanc, H. et al. (n.d.). 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models. Journal for immunotherapy of cancer. p. A640. [Online].